Ranran Tang

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Pentose phosphate pathway fuels cGAS-STING signalling to boost function of intratumoral conventional dendritic cells.

Pentose phosphate pathway fuels cGAS-STING signalling to boost function of intratumoral conventional dendritic cells.

Journal: Nature communications

Published: September 18, 2025

GENEasso: a curated resource of credible disease-gene associations across complex diseases from GWAS summary statistics.

GENEasso: a curated resource of credible disease-gene associations across complex diseases from GWAS summary statistics.

Journal: Nucleic acids research

Published: August 03, 2025

CROT overactivation within peroxisomes confers chemoresistance to non-small cell lung cancer by targeting fatty acid oxidation-Nrf2-ferroptosis resistance axis.

CROT overactivation within peroxisomes confers chemoresistance to non-small cell lung cancer by targeting fatty acid oxidation-Nrf2-ferroptosis resistance axis.

Journal: Pharmacological research

Published: May 07, 2025

Corrigendum to "MED27 promotes melanoma growth by targeting AKT/MAPK and NF/κB/iNOS signaling pathway" [Cancer Lett. 373(1) (2016) 77-87 PMID 26797421].

Corrigendum to "MED27 promotes melanoma growth by targeting AKT/MAPK and NF/κB/iNOS signaling pathway" [Cancer Lett. 373(1) (2016) 77-87 PMID 26797421].

Journal: Cancer letters

Published: April 24, 2025

Targeted nano-drug delivery systems for tumor immunotherapy.

Targeted nano-drug delivery systems for tumor immunotherapy.

Journal: Journal of pharmaceutical analysis

Published: March 10, 2025

Correction: Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits.

Correction: Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits.

Journal: Journal of experimental & clinical cancer research : CR

Published: June 26, 2024

KMT2A facilitates the epithelial-to-mesenchymal transition and the progression of ovarian cancer.

KMT2A facilitates the epithelial-to-mesenchymal transition and the progression of ovarian cancer.

Journal: Molecular and cellular biochemistry

Published: April 18, 2024

ASS1 enhances anoikis resistance via AMPK/CPT1A-mediated fatty acid metabolism in ovarian cancer.

ASS1 enhances anoikis resistance via AMPK/CPT1A-mediated fatty acid metabolism in ovarian cancer.

Journal: Cancer letters

Published: March 22, 2024

LINC00629, a HOXB4-downregulated long noncoding RNA, inhibits glycolysis and ovarian cancer progression by destabilizing c-Myc.

LINC00629, a HOXB4-downregulated long noncoding RNA, inhibits glycolysis and ovarian cancer progression by destabilizing c-Myc.

Journal: Cancer science

Published: October 10, 2023

Comprehensive Analysis of lncRNA and miRNA Regulatory Network Reveals Potential Prognostic Non-coding RNA Involved in Breast Cancer Progression.

Comprehensive Analysis of lncRNA and miRNA Regulatory Network Reveals Potential Prognostic Non-coding RNA Involved in Breast Cancer Progression.

Journal: Frontiers in genetics

Published: October 27, 2020

Upregulation of bromodomain PHD finger transcription factor in ovarian cancer and its critical role for cancer cell proliferation and survival.

Upregulation of bromodomain PHD finger transcription factor in ovarian cancer and its critical role for cancer cell proliferation and survival.

Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire

Published: September 28, 2020

LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via miR-455-5p and miR-491-5p sponging.

LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via miR-455-5p and miR-491-5p sponging.

Journal: Journal of cellular and molecular medicine

Published: July 05, 2020

Showing 1-12 of 38

Last Updated: 09/26/2026